Loading clinical trials...
Loading clinical trials...
Prucalopride based bowel cleansing regimen might be helpful to improve bowel cleansing quality before colonoscopy.
Colonoscopy is the standard approach for evaluating the colon currently. Thorough bowel cleansing is critical for adequate visualization of colonic mucosa during colonoscopy. Inadequate bowel cleansing results in adverse consequences for the examination, including lower adenoma detection rates, longer procedural time, lower cecal intubation rates, shorter intervals between examinations and an estimated 12-22% increase in overall colonoscopy cost.Unfortunately, despite advances in bowel preparation methods, up to one-third of all colonoscopies are reported to have an inadequate bowel preparation. Prucalopride can accelerate colonic transit and has been demonstrated to be efficient in constipation.
Age
18 - 70 years
Sex
ALL
Healthy Volunteers
No
Department of Gastroenterology, Qilu Hospital, Shandong University
Jinan, Shandong, China
Start Date
June 1, 2016
Primary Completion Date
March 1, 2017
Completion Date
March 1, 2017
Last Updated
May 27, 2016
600
ESTIMATED participants
2 mg Prucalopride plus 2 L Polyethylene Glycol regimen
DRUG
2 mg Placebo plus 2 L Polyethylene Glycol regimen
DRUG
Lead Sponsor
Shandong University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions